alogliptin 25 MG / pioglitazone 30 MG Oral Tablet [Oseni]
RxNorm concept 1368437, branded drug (sbd). Prescribable name: Oseni 25 MG / 30 MG Oral Tablet.
- RxCUI
- 1368437
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368437 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Oseni 25/30 (as alogliptin benzoate 34 MG / pioglitazone hydrochloride 33.06 MG) Oral Tablet; Oseni 25/30 Oral Tablet
Related concepts
- pioglitazone 30 MG (SCDC, consists of)
- alogliptin 25 MG (SCDC, consists of)
- alogliptin 25 MG / pioglitazone 30 MG [Oseni] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Oseni (BN, has ingredient)
- alogliptin 25 MG / pioglitazone 30 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1368437 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1368437 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1368437. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.